Study to Examine the Clinical Efficacy and the Nonsteroidal Anti-inflammatory Drug (NSAID)-Sparing Effect of Secukinumab Over 16 Weeks in Patients With Ankylosing Spondylitis
Clinical trial NCT02763046 · COMPLETED
Trial details
- NCT number
- NCT02763046
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-31
- Primary completion
- 2019-09-24
- Enrollment
- 211
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.